[1]耿争光,王琴,邓凯,等.遵义人群载脂蛋白A5 c.553G/T基因多态性 与混合型高脂血症的相关性研究[J].国际内分泌代谢杂志,2017,37(01):6-10.[doi:10.3760/cma.j.issn.1673-4157.2017.01.02]
　Geng Zhengguang*,Wang Qin,Deng Kai,et al.Association of apolipoprotein A5 c.553G/T gene polymorphism with combined hyperlipidemia in Zunyi population[J].International Journal of Endocrinology and Metabolism,2017,37(01):6-10.[doi:10.3760/cma.j.issn.1673-4157.2017.01.02]
点击复制

遵义人群载脂蛋白A5 c.553G/T基因多态性 与混合型高脂血症的相关性研究()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
37
期数:
2017年01期
页码:
6-10
栏目:
论著
出版日期:
2017-01-20

文章信息/Info

Title:
Association of apolipoprotein A5 c.553G/T gene polymorphism with combined hyperlipidemia in Zunyi population
作者:
耿争光; 王琴; 邓凯; 陈彬彬; 张志敏
563099 遵义医学院(耿争光,王琴,邓凯),医学遗传学教研室(张志敏); 563099 遵义医学院附属医院检验科(陈彬彬)
Author(s):
Geng Zhengguang*;  Wang Qin;  Deng Kai;  Chen Binbin;  Zhang Zhimin.
*Zunyi Medical College, Zunyi 563099, China
关键词:
载脂蛋白A5基因;  基因多态性;  混合型高脂血症
Keywords:
Apolipoprotein A5 gene;  Polymorphism;  Combined hyperlipidemia
DOI:
10.3760/cma.j.issn.1673-4157.2017.01.02
摘要:
目的 探讨遵义人群载脂蛋白A5(ApoA5)基因c.553G/T位点多态性与混合型高脂血症的相关性。方法 收集222名遵义地区人群静脉血标本,其中混合型高脂血症组100例,正常对照组122名,用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)技术检测两组标本ApoA5基因c.553G/T位点多态性,分析混合型高脂血症组和正常对照组中基因型频率和基因频率分布规律,及其与混合型高脂血症的关系。结果 ApoA5 c.553G/T位点基因型频率和基因频率在混合型高脂血症组与正常对照组差异有统计学意义(χ2=12.081,P=0.001; χ2=17.469,P<0.001); 通过 Logistic回归校正年龄、性别、血糖后,T等位基因携带者(TT+GT基因型)患高脂血症的风险较GG基因型携带者增加(OR=6.042, 95% CI:1.962～18.607,P=0.002)。结论 ApoA5 c.553G/T位点多态性与遵义地区人群混合型高脂血症发病存在一定相关性,ApoA5 c.553T等位基因可能是混合型高脂血症的独立危险因素。
Abstract:
Objective To investigate the relationship between c.553G/T polymorphism of apolipoprotein A5(ApoA5)gene and combined hyperlipidemia in Zunyi population. Methods Blood samples from 222 subjects including 100 patients with combined hyperlipidemia and 122 healthy individuals in Zunyi area were collected. c.553G/T polymorphism was tested by polymerase chain reaction and restriction fragment length polymorphism(PCR-RFLP)assay in both groups. The distribution of the genotypes and allele frequencies in the combined hyperlipidemia group and normal control group were analyzed, and its relationship with combined hyperlipidemia was analyzed. Results The genotypes and gene frequencies of the ApoA5 gene c.553G/T showed statistical difference between combined hyperlipidemia group and normal control group(χ2=12.081, P=0.001; χ2=17.469, P<0.001). The risk of hyperlipidemia for carriers of T alleles(TT or GT genotypes)was higher than those of GG genotypes(OR=6.042, 95% CI: 1.962-18.607, P=0.002), after adjusting age, gender and blood glucose by Logistic regression analysis. Conclusions ApoA5 gene c.553G/T polymorphisms has a relationship with combined hyperlipidemia in Zunyi population. It may be an independent risk factor for combined hyperlipidemia.

参考文献/References:

[1] 中国成人血脂异常防治指南制订联合委员会. 中国成人血脂异常防治指南[J]. 中华心血管病杂志, 2007, 35(5): 390-419.DOI:10.3760/j.issn: 0253-3758. 2007.05.003.
[2] 张沛然, 郭改会. 高脂血症的发病机制及分类 [J]. 中国临床医生, 2012, 40(3): 18-20. DOI:10.3969/j.issn.1008-1089.2012.03.005.
[3] Kao JT, Wen HC, Chien KL,et al. A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia[J].Hum Mol Genet,2003,12(19):2533-2539.DOI:10.1093/hmg/ddg255.
[4] Hallman DM, Srinivasan SR, Chen W,et al. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study[J].Metabolism,2006,55(12):1574-1581. DOI:10.1016/j.metabol.2006.07.018.
[5] Matsunaga A, Arishima H, Niimura H,et al. Strong linkage disequilibrium and association of -1131T>C and c.553G>T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population[J].Circ J,2007,71(5):746-752.
[6] Pennacchio LA, Olivier M, Hubacek JA,et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing[J].Science,2001,294(5540):169-173. DOI:10.1126/science.1064852.
[7] Liu ZK, Hu M, Baum L,et al. Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster withfamilial combined hyperlipidaemia in Hong Kong Chinese[J]. Atherosclerosis,2010,208(2):427-432. DOI: 10.1016/j.atherosclerosis.2009.08.013.
[8] 黄贤圣, 赵水平, 张骞, 等. 急性冠状动脉综合征患者载脂蛋白A5检测及其意义 [J]. 中华心血管病杂志, 2009, 37(10): 896-899.DOI:10.3760/cma. j.issn. 0253-3758. 2009.10.009.
[9] 谢印军, 黄刚, 邓峰美, 等. 载脂蛋白基因多态性与血脂关系研究进展[J]. 现代生物医学进展, 2010, 10(11): 2197-2200.
[10] Shoulders CC, Harry PJ, Lagrost L,et al. Variation at the apo AⅠ/CⅢ/AⅣ gene complex is associated with elevated plasma levels of apo CⅢ[J].Atherosclerosis,1991,87(2-3):239-247.
[11] 徐心, 张连凤. 载脂蛋白A5基因的研究进展[J]. 医学综述, 2010, 16(20): 3049-3051.DOI: 10.3969/j.issn.1006-2084.2010.20.004.
[12] 邱方, 张葵, 李雷, 等. 人载脂蛋白A5基因c.553 G>T多态性与血脂水平的相关性[J]. 临床检验杂志, 2007, 25(2): 120-122.DOI:10.3760/j.issn:1009-9158.2007.07.009.
[13] 陈伟, 干静, 周明珠, 等. 载脂蛋白A5 c553G/T基因多态性与缺血性脑卒中相关性研究[J]. 中国临床神经科学, 2009, 17(1): 26-30. DOI:10.3969/j.issn.1008-0678.2009.01.006.
[14] 安尼瓦尔·阿不里孜, 袁山, 马依彤, 等. 新疆维吾尔族与汉族载脂蛋白A5c.553G>T基因多态性分布特征及与血脂的关系 [J]. 中华医学杂志, 2011, 91(40): 2837-2840. DOI:10.3760/cma.j.issn.0376-2491.2011.40.009.
[15] 周心涛, 周恒, 丁研, 等. 载脂蛋白A5 c553G/T基因多态性与急性冠状动脉综合征的相关性[J]. 临床心血管病杂志, 2012, 28(8):590-592.DOI: 10.13201/j.issn.1001-1439.2012.08.010.
[16] 丁妍, 朱名安, 朱静, 等.代谢综合征患者载脂蛋白A5 c553G/T基因多态性分析[J].临床检验杂志, 2011, 29(5): 346-348. DOI:10.13602/j.cnki.jcls.2011.05.037.
[17] Pennacchio LA, Olivier M, Hubacek JA,et al. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels[J].Hum Mol Genet,2002,11(24):3031-3038.
[18] Ruiz-Narváez EA, Yang Y, Nakanishi Y, et al. APOC3/A5 haplotypes, lipid levels, and risk of myocardial infarction in the Central Valley of Costa Rica[J].J Lipid Res,2005,46(12):2605-2613. DOI:10.1194/jlr.M500040-JLR200.
[19] Chien KL, Chen MF, Hsu HC, et al. Genetic association study of APOA1/C3/A4/A5 gene cluster and haplotypes on triglyceride and HDL cholesterol in a community-based population[J].Clin Chim Acta,2008,388(1-2):78-83. DOI:10.1016/j.cca.2007.10.006.
[20] 张葵, 邱方, 李雷, 等. 脑梗死患者载脂蛋白A5基因多态性与颈动脉粥样硬化程度的相关性研究[J]. 检验医学,2008,23(5):504-508.DOI:10.3969/j.issn.1673-8640.2008.05.024.

相似文献/References:

[1]冯娟,夏维波.维生素D结合蛋白研究进展[J].国际内分泌代谢杂志,2016,36(03):209.[doi:10.3760/cma.j.issn.1673-4157.2016.03.17]
　Feng Juan,Xia Weibo.Research progress of vitamin D binding protein[J].International Journal of Endocrinology and Metabolism,2016,36(01):209.[doi:10.3760/cma.j.issn.1673-4157.2016.03.17]
[2]刘晓妮 王颖 李桃桃 马小敏 梁彦.血管紧张素转换酶基因rs4353多态性 与糖尿病微血管病变的相关性研究[J].国际内分泌代谢杂志,2018,38(03):149.[doi:10.3760/cma.j.issn.1673-4157.2018.03.002]
　Liu Xiaoni*,Wang Ying,Li Taotao,et al.Association between angiotensin converting enzyme gene rs4353 polymorphism and diabetic microangiopathy[J].International Journal of Endocrinology and Metabolism,2018,38(01):149.[doi:10.3760/cma.j.issn.1673-4157.2018.03.002]
[3]孙树凯 翟玉娥 田清武 赵鹏 申井利 翟木绪.雌激素受体基因多态性与妊娠糖尿病的 相关性研究[J].国际内分泌代谢杂志,2018,38(06):361.[doi:10.3760/cma.j.issn.1673-4157.2018.06.001]
　Sun Shukai*,Zhai Yu'e,Tian Qingwu,et al.Correlation between polymorphism of estrogen receptor gene and gestational diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2018,38(01):361.[doi:10.3760/cma.j.issn.1673-4157.2018.06.001]
[4]潘娟 陈霞.2型糖尿病患者FNDC5基因多态性 与颈动脉粥样硬化相关性研究[J].国际内分泌代谢杂志,2019,39(03):155.[doi:10.3760/cma.j.issn.1673-4157.2019.03.003]
　Pan Juan,Chen Xia.Association between FNDC5 gene polymorphism and carotid atherosclerosis in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2019,39(01):155.[doi:10.3760/cma.j.issn.1673-4157.2019.03.003]
[5]梁绮君 余寿益 胡晨鸣 李淑华 陈诗慧 杨焱 莫巧璇.乙醛脱氢酶2基因多态性与空腹血糖受损的 相关性[J].国际内分泌代谢杂志,2019,39(04):222.[doi:10.3760/cma.j.issn.1673-4157.2019.04.002]
　Liang Qijun,Yu Shouyi,Hu Chenming,et al.Association of aldehyde dehydrogenase 2 genetic polymorphism and impaired fasting glucose[J].International Journal of Endocrinology and Metabolism,2019,39(01):222.[doi:10.3760/cma.j.issn.1673-4157.2019.04.002]
[6]王英楠,成志锋.ABCG2基因多态性与痛风[J].国际内分泌代谢杂志,2020,40(05):351.[doi:10.3760/cma.j.cn121383-20200216-02026]
　Wang Yingnan,Cheng Zhifeng.ABCG2 Gene polymorphism and gout Medical University, Harbin 150001, China[J].International Journal of Endocrinology and Metabolism,2020,40(01):351.[doi:10.3760/cma.j.cn121383-20200216-02026]
[7]高虹,杨静,高飞.维生素D受体基因多态性与亚洲绝经后女性骨密度相关性的荟萃分析[J].国际内分泌代谢杂志,2021,41(03):158.[doi:10.3760/cma.j.cn121383-20210225-02058]
　Gao Hong,Yang Jing,Gao Fei..A meta-analysis of the association between vitamin D receptor gene polymorphism and bone mineral density in Asian postmenopausal women[J].International Journal of Endocrinology and Metabolism,2021,41(01):158.[doi:10.3760/cma.j.cn121383-20210225-02058]
[8]卓然然,付盼盼.IL-16基因多态性与GDM的关系及对妊娠结局的影响[J].国际内分泌代谢杂志,2022,42(02):118.[doi:10.3760/cma.j.cn121383-20210106-01014]
　Zhuo Ranran,Fu Panpan..Association between IL-16 gene polymorphism and susceptibility to GDM and its influence on pregnancy outcome[J].International Journal of Endocrinology and Metabolism,2022,42(01):118.[doi:10.3760/cma.j.cn121383-20210106-01014]
[9]李赫岩,滕卫平,单忠艳,等.内分泌腺体中磷酸二酯酶的分布及作用研究进展[J].国际内分泌代谢杂志,2022,42(02):129.[doi:10.3760/cma.j.cn121383-20201201-12003]
　Li Heyan,Teng Weiping,Shan Zhongyan,et al.Distribution and function of phosphodiesterases in endocrine glands[J].International Journal of Endocrinology and Metabolism,2022,42(01):129.[doi:10.3760/cma.j.cn121383-20201201-12003]

备注/Memo

备注/Memo:
基金项目:贵州省科技厅联合基金资助项目(黔科合J字LKZ [2012]39号); 遵义医学院大学生创新创业训练计划项目(院发[2014]5828) 通信作者:张志敏,Email:zzm_zhangzhimin@126.com
更新日期/Last Update: 2017-01-20